EXAGEN INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
EXAGEN INC. (XGN) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 19.00 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-04
- EXAGEN INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 9.00K shares.
- EXAGEN INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 10.00K shares.
- EXAGEN INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2020-12-31 was 48.66K shares, a 51.17% decline year-over-year.
- EXAGEN INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2020-09-30 was 22.45K shares.
- EXAGEN INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 9.62K shares, a 78.08% decline from fiscal 2023.
- EXAGEN INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 43.90K shares, a 82.99% decline from fiscal 2022.
- EXAGEN INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 257.98K shares, a 100.51% increase from fiscal 2021.
- EXAGEN INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2021 was 128.66K shares, a 56.15% decline from fiscal 2020.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 9.00K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | 19.00K shares 10-Q · filed 2026-08-04 | ||
| 2026-03-31 | 10.00K shares 10-Q · filed 2026-05-11 | |||
| 2024-12-31 | 9.62K shares 10-K · filed 2025-03-11 | |||
| 2023-12-31 | 43.90K shares 10-K · filed 2024-03-18 | |||
| 2022-12-31 | 257.98K shares 10-K · filed 2023-03-20 | |||
| 2021-12-31 | 128.66K shares 10-K · filed 2022-03-22 | |||
| 2020-12-31 | 48.66K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-16 | 71.12K shares derived: sum of 2 quarters · filed 2021-03-16 | 77.87K shares derived: sum of 3 quarters · filed 2021-03-16 | 293.41K shares 10-K · filed 2021-03-16 |
| 2020-09-30 | 22.45K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | 29.21K shares derived: sum of 2 quarters · filed 2020-11-10 | 244.75K shares 10-Q · filed 2020-11-10 | 344.41K shares derived: sum of 4 quarters · filed 2020-11-10 |
| 2020-06-30 | 6.75K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-28 | 222.30K shares 10-Q · filed 2020-07-28 | 321.95K shares derived: sum of 3 quarters · filed 2020-07-28 | |
| 2020-03-31 | 215.54K shares 10-Q · filed 2020-05-11 | 315.20K shares derived: sum of 2 quarters · filed 2020-05-11 | ||
| 2019-12-31 | 99.66K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25 | 99.97K shares 10-K · filed 2020-03-25 | ||
| 2019-09-30 | 310.00 shares 10-Q · filed 2019-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |